Peer-Reviewed Publications
Global Estimates of Individuals at Risk for Alzheimer's Disease Across the Disease Continuum
A 2022 study published by PAVE in Alzheimer's & Dementia highlights prevalence of Alzheimer's disease across disease stages. Findings suggest that a majority of patients are asymptomatic or preclinical.
Estimates of Current Capacity for Diagnosing Alzheimer's Disease in Sweden and the Need to Expand Specialist Numbers
This study assesses Sweden's current capacity to diagnose patients eligible for disease-modifying AD treatment in a timely manner and estimates the investment needed to reduce wait times.
PAVE Reports and White Papers
Report: From Innovation to Impact — Introducing Project Alzheimer's Value Europe
This report summarizes key insights from the PIAdT Working Group and introduces opportunities for the PAVE initiative to support timely access to Alzheimer's innovations through improved models for value assessment.
White Paper: How Alzheimer's Disease Registries Can Facilitate Holistic Value Assessments
This paper highlights PAVE's research findings around the present use of — and future opportunities for — European AD registries to support holistic value assessment.
Commentary: Overcoming the Barriers to Value Assessment of New Innovations in Alzheimer's Disease
This report reviews assessment methods currently employed by European HTA bodies to identify challenges and opportunities related to holistic value assessment of AD therapies.